Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer-Reference-Cited by-同舟云学术

Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer

Published:2017-03 Issue:2 Volume:18 Page:234-240.e2
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Okuma Hitomi Sumiyoshi,Horinouchi Hidehito^ORCID,Kitahara Shinsuke,Asao Tetsuhiko,Sunami Kuniko,Goto Yasushi,Kanda Shintaro,Fujiwara Yutaka,Nokihara Hiroshi,Yamamoto Noboru,Ohe Yuichiro

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths;Siegel;CA Cancer J Clin,2011

2. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

3. Small-cell lung cancer;Jackman;Lancet,2005

4. Chemotherapy for small cell lung cancer;Witta,2005

5. Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732;Niell;J Clin Oncol,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influencing factors of efficacy and long‐term use of amrubicin in patients with small cell lung cancer;Thoracic Cancer;2023-03-30

2. Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer;The Oncologist;2020-09-23

3. Efficacy of weekly amrubicin for refractory or relapsed non-small cell lung cancer;Medicine;2020-06-19

4. Immune checkpoint inhibition in small cell lung cancer: a key to reach an unmet need?;Translational Cancer Research;2017-12

5. Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study;Journal of Clinical Oncology;2017-12-01